Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Axsome Therapeutics (AXSM) Debt Ratio (2022 - 2025)

Axsome Therapeutics (AXSM) has disclosed Debt Ratio for 4 consecutive years, with 0.19 as the latest value for Q4 2025.

  • Quarterly Debt Ratio fell 41.73% to 0.19 in Q4 2025 from the year-ago period, while the trailing twelve-month figure was 0.19 through Dec 2025, down 41.73% year-over-year, with the annual reading at 0.19 for FY2025, 41.73% down from the prior year.
  • Debt Ratio hit 0.19 in Q4 2025 for Axsome Therapeutics, down from 0.28 in the prior quarter.
  • In the past five years, Debt Ratio ranged from a high of 0.56 in Q1 2022 to a low of 0.19 in Q4 2025.
  • Historically, Debt Ratio has averaged 0.34 across 4 years, with a median of 0.32 in 2024.
  • Biggest five-year swings in Debt Ratio: tumbled 45.61% in 2023 and later rose 13.52% in 2024.
  • Year by year, Debt Ratio stood at 0.3 in 2022, then increased by 3.79% to 0.31 in 2023, then rose by 1.36% to 0.32 in 2024, then tumbled by 41.73% to 0.19 in 2025.
  • Business Quant data shows Debt Ratio for AXSM at 0.19 in Q4 2025, 0.28 in Q3 2025, and 0.29 in Q2 2025.